Wednesday, 22 Jan 2020

PsA/SpA

Datesort ascending Type Title Save
13 Nov 2019 Social RT @Janetbirdope: 1/3 of pts using apremilast with PsA/SpA from Corrona data base are using it in combination with bDMARDs. Not sure how th…
13 Nov 2019 Social RT @uptoTate: MAXIMISE results in axial manifestations of PsA. SEC met primary phase 3b ASAS 20 endpoint after inadequate NSAID response. h…
13 Nov 2019 ACR Video Myosin Regulation May Contribute to Anti-TNF Therapy Response: Dr. Elaine Husni
13 Nov 2019 Social RT @uptoTate: Tildrakizumab (TIL), anti–IL-23p19 monoclonal ab, superior to PBO in phase 2b trial results in PsA. https://t.co/i0vIEHD4hx #…
13 Nov 2019 Social RT @uptoTate: Phase 2b Bimekizumab study results in PsA shows neutralizing IL 17F and IL 17A may be a new target for LDA/treatment. https:…
13 Nov 2019 Social RT @uptoTate: Risankizumab (RZB), humanized IgG1 monoclonal antibody and selective IL23p19 inhibitor, superior to PBO in PsA. Initial phase…
13 Nov 2019 Social RT @uptoTate: Go-DACT proof on concept results: golimumab + MTX superior to monotherapy MTX in PsA dactylitis. https://t.co/dEGnjiuGZf #ACR…
13 Nov 2019 Social RT @EBRheum: #ACR19 Abst#2877: Open Label Extension of a Phase 2 for risankizumab (IL23i) for PsA Effect seems to stick around and favorab…
12 Nov 2019 Social RT @philipcrobinson: Video from @gensler_MD on AS and nr-axSpA studies presented at #ACR19 @rheumnow https://t.co/fcn9zCxouU via @YouTube
12 Nov 2019 Social RT @philipcrobinson: Pregnancy outcome in the DESIR cohort (SpA cohort) #ACR19 @RheumNow https://t.co/PcwR6rrMRw
12 Nov 2019 Social RT @DrPetryna: #ACR19 @rheumnow L20 head-to-head IXE vs ADA PSA 52wk trial: IXE shows significantly ⬆️ response than ADA for simultaneous…
12 Nov 2019 Social RT @hausmannMD: Ixekizumab is a high-affinity monoclonal antibody against interleukin-17A. In patients with psoriatic arthritis, ixekizuma…
12 Nov 2019 Social RT @psufka: Abstr# 2440: Strong association between psoriatic arthritis and osteoporosis (45%) and osteopenia (13%). A good reminder to scr…
12 Nov 2019 Social RT @synovialjoints: 5-year effectiveness of TNFi in patients with early axSpA shown, male gender, HLAB27 positive and presence of at least…
12 Nov 2019 Social RT @DrPetryna: @RheumNow #ACR19 #acrbest abs2470 ⬆️serum calprotectin in PsA pts associated w/presence of carotid plaque, ⬆️intima-media th…
12 Nov 2019 Social RT @DrPetryna: @rheumnow #ACR19 abs2854 internationPsART cohort data: age of onset defines if PSO or PSA starts first (PSO precedes in you…
12 Nov 2019 Social RT @uptoTate: The updated ACR/NPF treatment recommendations for PsA were discussed by Dr. Mease and Dr. E. Husni at #ACR19. Will you start…
12 Nov 2019 Social RT @uptoTate: Dr. Mease discusses the ACR/NPF recommendations for treatment naive PsA pts. This slide details starting with TNFi for patien…
12 Nov 2019 Social RT @DrPetryna: @RheumNow #ACR19 abs2467 multicenter observational study analysis concludes sleep impairment in PsA is mainly mediated by su…
12 Nov 2019 Social RT @uptoTate: COAST-X: IXE met ASAS 40 and all secondary endpoints in nr-axSpA vs PBO. https://t.co/V0QNfi33eA #ACR19 @RheumNow plenary#272…